Protein Name |
Platform |
Matrix |
Range |
EPO |
ELISA |
Plasma |
2.5 – 200 mIU/mL |
Insulin |
ELISA |
Plasma |
5 – 500 pg/mL |
Exenatide |
ELISA |
Plasma |
10 – 300 pg/mL |
IFN-gamma |
ELISA |
Serum |
15 – 1000 pg/mL |
IFN-alpha |
ELISA |
Serum |
15 – 500 pg/mL |
Herceptin |
MSD |
Serum |
2 – 1000 ng/mL |
Anti-IL5 |
ELISA |
Plasma |
100 – 5000 ng/mL |
Anti-CD20 |
ELISA |
Plasma |
100 – 2500 ng/mL |
GLP-1 |
ELISA |
Plasma |
1 – 1000 pg/mL |
IL-5 |
ELISA |
Plasma/Medium |
4 – 250 pg/mL |
VEGF |
ELISA |
Plasma/Medium |
6 – 4000 pg/mL |
PEG |
ELISA |
Plasma/Medium |
4 – 640 ng/mL |
EGF |
ELISA |
Plasma/Medium |
4 – 250 pg/mL |
TNF-alpha |
MSD |
Plasma/Medium |
2 – 2500 pg/mL |
IL-1 alpha |
ELISA |
Plasma/Medium |
3 – 250 pg/mL |
IL-1 beta |
MSD |
Plasma/Medium |
5 – 10,000 pg/mL |
IL-6 |
MSD |
Plasma/Medium |
5 – 10,000 pg/mL |
MCP-1 |
ELISA |
Plasma/Medium |
30 – 200 pg/mL |
IGF-1 |
ELISA |
Plasma/Medium |
100 – 6000 pg/mL |
PDGF-BB |
ELISA |
Plasma/Medium |
30 – 2000 pg/mL |
Amyloid β 1-42 |
ELISA |
CSF/Plasma |
32- 1000 pg/mL |
ICAM-1 |
ELISA |
Plasma/Medium |
2 – 50 ng/mL |
VCAM-1 |
ELISA |
Plasma/Medium |
6 – 200 ng/mL |
MMP-1 |
ELISA |
Plasma/Medium |
100 – 10000 pg/mL |
IL-8 |
ELISA |
Plasma/Medium |
30 – 2000 pg/mL |
TGF-alpha |
ELISA |
Plasma/Medium |
15 – 1000 pg/mL |
Anti-TGFbRII |
Gyrolab |
Serum |
5 – 3000 ng/mL |
Anti-TNFRSF4 |
Gyrolab |
Plasma |
1 – 300 mg/mL |
iC3b |
ELISA |
Plasma |
0.5 – 200 mg/mL |
CFI |
ELISA |
Plasma |
50 – 4000 ng/mL |
Complement Factor Bb |
ELISA |
Plasma |
63 – 593 ng/mL |
Complement Factor B |
ELISA |
Plasma |
4.375 – 280 ng/mL |
CFI Activity |
In Vitro Functional Assay |
Plasma |
Inquire |
CFH Activity |
In Vitro Functional Assay |
Plasma |
Inquire |
|
|
|
|
|
Assay Name |
Platform |
Cell Type |
Proliferation |
Cell-based |
Endothelial cells, smooth muscle cells |
Apoptosis |
Cell-based |
Tumor cells |
Antibody Neutralizing |
Cell-based |
Tumor cells |
Adhesion |
Cell-based |
Fibroblast Cells, Epithelial cells |
Cytotoxicity |
Cell-based |
Endothelial cells, Tumor cells |